Therapy News and Research

RSS

Common drug could mitigate risk of 'a broken heart' during bereavement

The increased risk of heart attack or "a broken heart" in early bereavement could be reduced by using common medication in a novel way, according to a world-first study led by the University of Sydney and funded by Heart Research Australia.

10 Feb 2020

Outcomes-based drug reimbursement may be on the horizon, report says

How can pharma and life sciences be prepared and agile enough to respond to future challenges if it has not thought about the current trends and emerging challenges?

10 Feb 2020

Research reveals novel way to treat cancers using CAR T cell therapy

Too many patients with cancers like multiple myeloma relapse after treatment. This grim reality motivated researchers at Huntsman Cancer Institute at the University of Utah to try to improve the depth and durability of treatment response in multiple myeloma through a new cancer cell targeting mechanism.

10 Feb 2020

CRISPR-edited immune cells can be safely given to cancer patients

The emergence of CRISPR-Cas9 gene-editing technology has spurred hope in both doctors and patients since it shows promise in treating a multitude of diseases, including cancer. For the first time in the United States, a team of scientists has shown that CRISPR-edited immune cells can be safely used to cancer patients.

9 Feb 2020

Robot that can draw blood in humans

Soon, robots can take blood samples that can benefit both patients and healthcare workers, thanks to a new blood-sampling robot. A few years back, it was developed but was only tested on plastic arms. Now, the robot has been successfully trialed on live humans.

9 Feb 2020

Vibratory and auditory stimulation improves the amount, quality of sleep in insomnia patients

Many people find it easier to sleep in a car or a train because of the vibration and noise that helps "rock" them to sleep. But a more specific approach for using a vibratory and auditory stimulation program helps improve brain function and sleep amount and quality in patients with insomnia, according to a study published in the journal, Sleep Disorders.

9 Feb 2020

Smoking cessation goody bag helps people quit smoking

While sitting in the dentist's office, Hollings Cancer Center researcher Matthew Carpenter, Ph.D., of the Medical University of South Carolina, had a bright idea.

9 Feb 2020

Scientists come together to better understand patented innovations available for gene therapy

The global gene therapy market is expected to reach $13 billion by 2024 as new treatment options target cancers and other diseases.

9 Feb 2020

Researchers evaluate effectiveness of medication assisted therapy for opioid use disorder

Rebecca Sutter, Assistant Professor, School of Nursing, College of Health and Human Services, and Allison Evans Cuellar, Professor, Health Administration and Policy, CHHS, are implementing and evaluating the effectiveness of a Mobile Medication Assisted Therapy Program in the Prince William Health District that will expand capacity for opioid use disorder support and services.

9 Feb 2020

St. Jude's researchers receive ACGT grant to tackle challenges of pediatric sarcomas

An innovative approach to tackling the challenges of pediatric sarcomas is being pursued by researchers at St. Jude Children's Research Hospital (Memphis, Tennessee) with a new grant from Alliance for Cancer Gene Therapy.

9 Feb 2020

Researchers reveal how long coronaviruses persist on surfaces and a way for inactivation

The novel coronavirus 2019-nCoV is making headlines worldwide. Since there is no specific therapy against it, the prevention of infection is of particular importance in order to stem the epidemic.

9 Feb 2020

Acute Cardiovascular Care 2020 will highlight novel research on recovery from heart emergencies

Innovative research in the diagnosis and treatment of heart emergencies will be revealed at Acute Cardiovascular Care 2020, a scientific congress of the European Society of Cardiology.

9 Feb 2020

New therapeutic strategy for lung cancer and associated secondary tumors

In 20 - 40% of patients with cancer, metastasis (the development of secondary tumors) in the central nervous system (CNS) occurs. CNS metastatis impacts negatively on a patient's quality of life, and is associated with a poor health prognosis.

8 Feb 2020

New gene therapy improves vision in blind mice

Mice born blind have shown significant improvement in vision after undergoing a new gene therapy developed by a team of Japanese scientists.

7 Feb 2020

Gene therapy approach could pave the way for treatment of Stargardt disease

A leading Professor of Ophthalmology at the University of Oxford has shared the details of his research which could pave the way for a new treatment for sight loss condition Stargardt disease.

7 Feb 2020

Researchers discover new approach to make tumors sensitive to immunotherapy

A cancer tumor's ability to mutate allows it to escape from chemotherapy and other attempts to kill it. So, encouraging mutations would not be a logical path for cancer researchers.

7 Feb 2020

Researchers reveal new activity above the surface in brain-cell receptors

Like buoys bobbing on the ocean, many receptors float on the surface of a cell's membrane with a part sticking above the water and another underwater, inside the cell's cytoplasm.

7 Feb 2020

Rejuvenate Bio secures license to commercialize gene therapy for treating age-related diseases in dogs

Rejuvenate Bio has secured a license to commercialize a gene therapy technology developed at the Wyss Institute to treat multiple age-related diseases in dogs, which could open the door to similar treatments for humans in the future.

6 Feb 2020

CD19 CAR NK cell therapy clinical trial shows encouraging results for hematologic cancers

According to results from a Phase I/IIa trial at The University of Texas MD Anderson Cancer Center, treatment with cord blood-derived chimeric antigen receptor natural killer (NK)-cell therapy targeting CD19 resulted in clinical responses in a majority of patients with relapsed or refractory non-Hodgkin's lymphoma and chronic lymphocytic leukemia, with no major toxicities observed.

6 Feb 2020

Online version of MBCT for lingering depression symptoms improves access to care

An online version of a pioneering therapy aimed at reducing the lingering symptoms of depression can offer additional benefits for patients receiving care, according to a new U of T Scarborough study.

6 Feb 2020

Therapy News and Research

Common drug could mitigate risk of 'a broken heart' during bereavement

Outcomes-based drug reimbursement may be on the horizon, report says

Research reveals novel way to treat cancers using CAR T cell therapy

CRISPR-edited immune cells can be safely given to cancer patients

Robot that can draw blood in humans

Vibratory and auditory stimulation improves the amount, quality of sleep in insomnia patients

Smoking cessation goody bag helps people quit smoking

Scientists come together to better understand patented innovations available for gene therapy

Researchers evaluate effectiveness of medication assisted therapy for opioid use disorder

St. Jude's researchers receive ACGT grant to tackle challenges of pediatric sarcomas

Researchers reveal how long coronaviruses persist on surfaces and a way for inactivation

Acute Cardiovascular Care 2020 will highlight novel research on recovery from heart emergencies

New therapeutic strategy for lung cancer and associated secondary tumors

New gene therapy improves vision in blind mice

Gene therapy approach could pave the way for treatment of Stargardt disease

Researchers discover new approach to make tumors sensitive to immunotherapy

Researchers reveal new activity above the surface in brain-cell receptors

Rejuvenate Bio secures license to commercialize gene therapy for treating age-related diseases in dogs

CD19 CAR NK cell therapy clinical trial shows encouraging results for hematologic cancers

Online version of MBCT for lingering depression symptoms improves access to care

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News